TSXV:KDA

Stock Analysis Report

Executive Summary

KDA Group Inc. provides pharmacy personnel replacement and vocational training services to health industry in the Province of Quebec, Canada.


Snowflake Analysis

Weak fundamentals or lack of information.

Share Price & News

How has KDA Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: KDA's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

2.8%

KDA

-2.0%

CA Healthcare

0.1%

CA Market


1 Year Return

37.0%

KDA

-11.6%

CA Healthcare

4.5%

CA Market

Return vs Industry: KDA exceeded the Canadian Healthcare industry which returned -11% over the past year.

Return vs Market: KDA underperformed the Canadian Market which returned 4.7% over the past year.


Shareholder returns

KDAIndustryMarket
7 Day2.8%-2.0%0.1%
30 Day-17.8%0.6%0.9%
90 Day-37.3%6.3%3.7%
1 Year37.0%37.0%-9.1%-11.6%7.8%4.5%
3 Year-58.9%-58.9%-14.6%-25.2%18.2%7.5%
5 Year8.8%8.8%28.1%-0.7%33.7%14.2%

Price Volatility Vs. Market

How volatile is KDA Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is KDA Group undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether KDA Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as KDA Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of KDA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through KDA Group regulatory filings.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is KDA Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

38.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as KDA Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has KDA Group performed over the past 5 years?

-41.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: KDA is currently unprofitable.

Growing Profit Margin: KDA is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: KDA is unprofitable, and losses have increased over the past 5 years at a rate of -41.3% per year.

Accelerating Growth: Unable to compare KDA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: KDA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (0.6%).


Return on Equity

High ROE: KDA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is KDA Group's financial position?


Financial Position Analysis

Short Term Liabilities: KDA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: KDA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: KDA has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: KDA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: KDA has a low level of unsold assets or inventory.

Debt Coverage by Assets: KDA has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: KDA has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: KDA has less than a year of cash runway if free cash flow continues to reduce at historical rates of -16% each year


Next Steps

Dividend

What is KDA Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%5.4%industryaverage1.4%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate KDA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate KDA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if KDA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if KDA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of KDA's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average management tenure


CEO

Marc Lemieux 0

4.4yrs

Tenure

CA$213,000

Compensation

Mr. Marc Lemieux is the Co-Founder of AlliancePharma Inc (now, KDA Group Inc.) and serves as its Chairman. Mr. Lemieux has been Chief Executive Officer and President of KDA Group Inc. since September 2015  ...


CEO Compensation Analysis

Compensation vs Market: Marc's total compensation ($USD0.00) is below average for companies of similar size in the Canadian market ($USD154.65K).

Compensation vs Earnings: Marc's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Marc Lemieux
Co-Founder4.4yrsCA$213.00k8.83% CA$1.9m
Isabelle Bégin
Co-Founder5.1yrsCA$134.09k4.88% CA$1.1m
Michael Kinley
Interim CFO & Director5.1yrsCA$12.00k0.0057% CA$1.2k
Giuseppe D'Aprano
Chief Scientific Officer0.7yrsno datano data

1.9yrs

Average Tenure

Experienced Management: KDA's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Marc Lemieux
Co-Founder4.4yrsCA$213.00k8.83% CA$1.9m
Isabelle Bégin
Co-Founder5.1yrsCA$134.09k4.88% CA$1.1m
Michael Kinley
Interim CFO & Director5.1yrsCA$12.00k0.0057% CA$1.2k
Sheldon Elman
Independent Director3.5yrsno datano data
Stuart Elman
Independent Director3.6yrsno datano data
Stan Bharti
Director0.3yrsno datano data
Patrick Fernet
Independent Director5.1yrsCA$125.00k1.17% CA$253.9k

4.3yrs

Average Tenure

Experienced Board: KDA's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 113.6%.


Top Shareholders

Company Information

KDA Group Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: KDA Group Inc.
  • Ticker: KDA
  • Exchange: TSXV
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$21.646m
  • Shares outstanding: 117.01m
  • Website: https://groupekda.ca

Number of Employees


Location

  • KDA Group Inc.
  • 1351 Notre-Dame Street East
  • Suite 300
  • Thetford Mines
  • Quebec
  • G6G 0G5
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
KDATSXV (TSX Venture Exchange)YesCommon SharesCACADJan 2015

Biography

KDA Group Inc. provides pharmacy personnel replacement and vocational training services to health industry in the Province of Quebec, Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Pharmaceutical Cannabis Products. It offers online and in-class training services for pharmacists and pharmacy technical assistants; and human resource and crisis management consulting services. The company also distributes generic drugs. In addition, it is involved in the cultivation of cannabis for the pharmaceutical applications. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. is headquartered in Thetford Mines, Canada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/24 02:37
End of Day Share Price2020/02/21 00:00
Earnings2019/10/31
Annual Earnings2019/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.